Phase I study of immunization with dendritic cells (DC) modified with recombinant fowlpox encoding carcinoembryonic antigen (CEA) and the triad of costimulatory molecules CD54, CD58, and CD80 (rF-CEA(6D)-TRICOM) in patients with advanced malignanciesMichael Morse, H. Kim Lyerly, Timothy Clay et al.|Journal of Clinical Oncology|2004Cited by 4